MedTrace Logo

Trial to Compare Intra-individually the Efficacy and Tolerance of Oleogel-S10 Versus Moist Wound Healing Dressing Alone in Accelerating the Epithelialization of Split Thickness Skin Graft Donor Sites

NCT01294254 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2015-04-03

No results posted yet for this study

Summary

In this study the wound reepithelialization of that part of the skin graft donor site, which is treated with Oleogel-S10 compared to that part of the wound, which is covered by moist wound healing dressing alone will be investigated.

Conditions

  • Accelerating the Epithelialization of Split Thickness Skin Graft

Interventions

DRUG

Oleogel-S10

Oleogel-S10 on one half of the skin graft donor site (each time when the wound dressing is changed during a time period of 14 days, normally once daily)

PROCEDURE

Moist wound healing dressings alone (Mepilex) on the other half of the skin graft donor site

wound is covered conventionally by applying one half of the Mepilex cut

Sponsors & Collaborators

  • Birken AG

    lead INDUSTRY

Principal Investigators

  • Hans Robert Metelmann, Prof. Dr. med. · University Hospital of Ernst-Moritz-Arndt-University Greifswald

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2010-11-30
Completion
2010-11-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01294254 on ClinicalTrials.gov